CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
REVENUE
Revenue		$ 40,816
TOTAL REVENUE		40,816
OPERATING EXPENSES
Research and development	$ 5,115,699	3,296,322
General and administrative	2,715,835	1,905,582
TOTAL OPERATING EXPENSES	7,831,534	5,201,904
LOSS FROM OPERATIONS	(7,831,534)	(5,161,088)
OTHER INCOME (EXPENSE)
Investment income	13,440	9,165
TOTAL OTHER INCOME (EXPENSE)	13,440	9,165
NET LOSS	$ (7,818,094)	$ (5,151,923)
Net loss per share, basic	$ (0.32)	$ (0.23)
Net loss per share, diluted	$ (0.32)	$ (0.23)
Weighted-average number of shares of common stock outstanding basic	24,282,743	22,228,723
Weighted-average number of shares of common stock outstanding diluted	24,282,743	22,228,723